ATCC 100 Years Logo Anniversary ATCC 100 Years Logo Anniversary Cart 0
  • Quick Order
  • Careers
  • Support

Development and Validation of a Quantitative Synthetic Analytical Reference Material for Monkeypox Virus

Poster
Monkeypox virus

APHL 2025 Annual Conference

Portland, Oregon, United States

May 05, 2025

Abstract

Mpox is a zoonotic viral disease caused by the human monkeypox virus (hMPXV), a double-stranded DNA virus that belongs to the genus Orthopoxvirus and the family Poxviridae. hMPXV is endemic to several countries in Central and Western Africa and has been increasingly appearing in non-endemic areas. The virus causes a smallpox-like disease in humans and is characterized by two distinct genetic clades: Clade I and Clade II. 

Rapid and accurate detection of this virus during the early stages of infection is essential for containment and timely treatment. While culture-based approaches can be used to detect hMPXV, they are typically time-consuming, labor-intensive, and require BSL-3 facilities. PCR-based methods provide a highly sensitive and rapid alternative screening approach. However, the development and validation of these assays depend on high-quality reference materials. To address this need, ATCC® designed and developed a quantitative synthetic molecular standard for hMPXV that contains specific hMPXV diagnostic biomarkers, including those characteristic of both clades. Here, we used a proprietary strategy to incorporate gene sequences typically targeted in various assays for viral detection to create a safe (BSL-1) and reliable positive analytical reference material (ARM). 

The hMPXV ARM was authenticated via next-generation sequencing and quantified via Droplet Digital PCR (ddPCR; Bio-Rad). The synthetic standard’s functionality was tested via 15 published quantitative PCR (qPCR) assays, including those from the Centers for Disease Control and Prevention (CDC) that are specific for non-variola Orthopoxvirus and generic monkeypox. Serial ten-fold dilutions were used to create standard curves, with DNA concentrations ranging from 5.0 x 105  copies/µL to 5 copies/µL. Within this data set, the hMPXV standard had R2 values of 0.975 to 0.999, with slopes ranging from -3.291 to -3.477, displaying high efficiency and amplification. 

The data collectively indicate that the hMPXV synthetic molecular standard is an effectively designed ARM suitable for developing and validating molecular-based detection and quantification assays. Our findings confirm the full compatibility of this novel ARM with 15 qPCR assays. Consequently, this ARM can function as a PCR template control, providing a safe and dependable positive control material for molecular assays employed in diagnostics and surveillance. 

Download the poster to explore the development and application of a monkeypox virus analytical reference material

Download

Presenters

Headshot of Leka Papazisi

Leka Papazisi, DVM, PhD

Principal Scientist, Research and Industrial Solutions, ATCC

Dr. Papazisi joined ATCC in 2019. His main responsibility is product development, from asset inception through lifecycle management. While at ATCC, Dr. Papazisi led the Microbiology R&D team in developing several new products, including a proprietary nucleic acid storage buffer formulation and various diagnostics control materials. In addition to technical leadership, his responsibilities include talent management, new product innovation, and management of internal and external cross-functional activities. Before joining ATCC, Dr. Papazisi worked for OpGen (2018-2019), Canon U.S. Life Sciences (2011-2018), and J. Craig Venter Institute (2003-2011). At OpGen, he directed the implementation of an antimicrobial-resistance surveillance system for the state of New York. While at Canon US Life Sciences, his main responsibility was the development of PCR-based assays and assay controls for detecting human inherited diseases and infectious agents—launching with his team ca. 700 products. At the JCVI, Dr. Papazisi led a variety of comparative genomic projects of several biothreat agents. During his academic career at the U. of Connecticut and Vet Med U. of Vienna, Dr. Papazisi studied genomics, virulence factors, and vaccine design for mycoplasmas as well as molecular profiling of Salmonella.

Holly_Asbury.jpg

Holly A. Asbury, BS

Senior Biologist, ATCC

Holly joined the Microbiology R&D team in 2020. She focuses on developing and supporting analytical reference material products in the ATCC catalog. Holly has participated in several stability studies to determine product shelf-life and works on developing and troubleshooting real-time PCR and digital PCR assays for new product development, manufacturing, and quality control.

Medical illustration of monbkeypox virus in light blue.

Monkeypox virus molecular diagnostics development

Accurate and rapid diagnosis of mpox is critical for timely healthcare and tracking of transmission. To support the need for increased monitoring, ATCC provides a variety of orthopoxviruses and nucleic acids that support assay development and validation. We have also developed a research use only (RUO) quantitative synthetic monkeypox virus DNA preparation with a sequence design based on several published assays.

Develop your mpox assay